FindTrial
Sign In

Tranexamic Acid Use in Elective Cesarean Section for Women With Placenta Previa

Tranexamic Acid Use in Elective Cesarean Section for Women With Placenta Previa: A Randomized Controlled Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03060889
Enrollment
86
Registered
2017-02-23
Start date
2016-02-29
Completion date
2016-12-31
Last updated
2017-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Placenta Previa

Keywords

Cesarean section, placenta previa, Tranexamic acid

Brief summary

Tranexamic Acid Use in Elective Cesarean Section for Women With Placenta Previa

Detailed description

Tranexamic Acid Use in Elective Cesarean Section for Women With Placenta Previa to detect efficacy of Tranexamic acid in decreasing blood loss

Interventions

DRUGTranexamic acid

10 mg/kg body weight will be given with induction of anesthesia by intravenous infusion

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* Term pregnancy (more than 37 weeks of gestation) * Diagnosis of placenta previa was confirmed by ultrasound * The patient hemoglobin percentage is more than 10 mg/dl

Exclusion criteria

* Invading placenta previa diagnosis was confirmed by Doppler ultrasound studies * Emergency lower segment cesarean section * Associated medical comorbidities

Design outcomes

Primary

MeasureTime frameDescription
intra operative blood loss in mlintraoperative during cesarean sectionCalculation of blood loss during cesarean section in the two groups to detect efficacy of Tranexamic acid in reducing blood loss

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026